Evidence map›Paper›PMID 38977587›Full record

ReviewMethods in molecular biology (Clifton, N.J.)2024

Nanoparticles and Their Applications in Lipid Signaling.

Zeinab Fotouhi Ashin, Ahmed S Yacoub, Marwa Saady, Sophia E Thompson, Kamal Awad, Pranesh Aswath, Marco Brotto, Venu Varanasi

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Methods in molecular biology (Clifton, N.J.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Zeinab Fotouhi AshinDepartment of Materials Science and Engineering, The University of Texas at Arlington, Arlington, TX, USA.
Ahmed S YacoubBone Muscle Research Center, The University of Texas at Arlington, Arlington, TX, USA.
Marwa SaadyChemistry Department, School of Sciences & Engineering, The American University in Cairo, Cairo, Egypt.
Sophia E ThompsonBone Muscle Research Center, The University of Texas at Arlington, Arlington, TX, USA.
Kamal AwadBone Muscle Research Center, The University of Texas at Arlington, Arlington, TX, USA.
Pranesh AswathDepartment of Materials Science and Engineering, The University of Texas at Arlington, Arlington, TX, USA.
Marco BrottoBone Muscle Research Center, The University of Texas at Arlington, Arlington, TX, USA.
Venu VaranasiDepartment of Materials Science and Engineering, The University of Texas at Arlington, Arlington, TX, USA. venu.varanasi@uta.edu.

Funding

Transgenic and Mechanical Loading CoreP01AG039355 · NIA · UNIVERSITY OF MISSOURI KANSAS CITY · PI BONEWALD, LYNDA F · 2012 to 2024
$19.3M
Regulation of Store-Operated Calcium Entry During Muscle AgingR01AG056504 · NIA · OHIO STATE UNIVERSITY · PI BROTTO, MARCO, WEISLEDER, NOAH · 2018 to 2022
$2.6M
Loss of Numb in Muscle Dysfunction in AgingR01AG060341 · NIA · BRONX VETERANS MEDICAL RESEARCH FDN · PI BROTTO, MARCO, CARDOZO, CHRISTOPHER P · 2018 to 2022
$2.4M
Semiconductor Biomaterials to Speed Bone Healing: A Bioengineering-Driven ApproachR01DE031872 · NIDCR · UNIVERSITY OF TEXAS ARLINGTON · PI Venu Gopal Varanasi · 2023 to 2026
$1.8M
An Inverted Nikon A1R Laser Scanning Confocal MicroscopeS10OD025230 · OD · UNIVERSITY OF TEXAS ARLINGTON · PI PAN, ZUI · 2019 to 2019
$449k
Printing and Regenerating Fractured Bone Using Antioxidant MaterialsR56DE027964 · NIDCR · UNIVERSITY OF TEXAS ARLINGTON · PI VARANASI, VENU GOPAL · 2019 to 2019
$428k
Silicon, a Novel Antioxidant Role in Bone HealingR03DE023872 · NIDCR · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI VARANASI, VENU GOPAL · 2014 to 2015
$229k
NIA NIH HHS P01 AG039355NIA NIH HHS R01 AG056504NIA NIH HHS R01 AG060341NIDCR NIH HHS R01 DE031872NIDCR NIH HHS R03 DE023872NIDCR NIH HHS R56 DE027964NIH HHS S10 OD025230
6 · The paper itself

Abstract

This chapter provides an overview of the diverse range of applications associated with nanoparticles. The application of nanoparticles in the medical field has garnered considerable attention due to their unique properties and versatile compositions. They have shown promise in the treatment of cancer, fungal and viral infections, and pain management. These systems provide numerous benefits, such as increased drug stability, improved bioavailability, and targeted delivery to specific tissues or cells. The objective of this chapter is to provide a brief analysis of the differences between nanoparticles and lipid particles, focusing particularly on the importance of nanoparticle size and composition in their interactions with lipids. Additionally, the applications of nanoparticles in lipid signaling will be discussed, considering the vital roles lipids play in cellular signaling pathways. Nanoparticles have shown immense potential in the regulation and control of medical pathways. In this case, we will focus on the manufacture of liposomes, a type of nanoparticle composed of lipids. The reason behind the extensive investigation into liposomes as drug delivery vehicles is their remarkable biocompatibility and adaptability. This section will provide insights into the methods and techniques employed for liposome formulation.

Indexed as

LipidsLiposomesNanoparticlesSignal TransductionAnimalsDrug Delivery SystemsHumansLipid MetabolismLipidsLiposomesDrug deliveryLipid nanoparticleLipid signalingLiposomesNanostructured lipid carriersSolid lipid nanoparticles

Identifiers

PMID38977587
PMCPMC11778244

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.